Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.65 0.21 (6.1%) Market Cap: 537.89 Mil Enterprise Value: 294.57 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 72/100

Adaptive Biotechnologies Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 03:45PM GMT
Release Date Price: $33.14 (+2.86%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Thank you, operator. Hi, good morning, everyone. This is Derik De Bruin, the senior analyst in the Life Sciences and Diagnostics Tools Group.

Welcome to the 2021 virtual Viva, Las Vegas, Bank of America Healthcare Conference. With me today from Bank of America is Ivy Ma, who focuses on diagnostics on our team. And joining us today for our next presentation is Chad Robins, Co-Founder and CEO of Adaptive Biotechnologies. Good morning, Chad.

Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Good morning, Derik. Good morning, Ivy. Thank you so much for having me.

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Great. So Chad, I think we've got a lot of questions to go through. It's been a really exciting time in Adaptive for the last year. COVID has certainly presented a really interesting opportunity for the company to sort of like demonstrate its platform. But I guess any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot